ORTEXORTEX News
Tracking DTE? Get live short interest, options flow, and signals on ORTEX.Sign up free →
DT
Trader NoteDTE

DTE Shorts Rebuild Ahead of October 29 Earnings

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 21 Oct 2026, 18:16

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

DTE Energy heads into its Q3 results with short sellers adding positions at their fastest monthly pace in recent memory, even as the stock holds ground against a broader utility rally.

Short interest has climbed 15% over the past month, reaching 2.8% of the free float as of October 20. That is still a modest absolute level, but the pace of rebuilding is notable: positions rose roughly 3.7% in the past week alone, with the share count moving from around 5.57 million to 5.77 million. The move has been steady rather than spiky, suggesting deliberate positioning rather than reactive covering. Days to cover, based on the most recent FINRA fortnightly data, stand at 2.4.

The borrow market gives no sign of stress on the short side. Availability remains extraordinarily loose at roughly 3,960% of short interest, meaning there are nearly 120 million shares available in the lending pool against fewer than 6 million currently borrowed. Cost to borrow is also negligible at 0.43%, down 15% over the past month. For context, the tightest availability has been over the past year was 1,554% in the same metric, which is itself extremely loose. There is no squeeze pressure here, and new shorts can enter the borrow market without friction.

Analyst sentiment has been tilting cautious on price targets while ratings broadly hold. Morgan Stanley lowered its target to $139 this week, maintaining Overweight. Barclays made the sharper move on October 16, cutting its target to $135 from $154 while staying at Equal-Weight. Truist trimmed to $150 from $160, retaining Buy. BMO Capital, by contrast, nudged its target up to $139 from $134 on the same day. The consensus mean target sits at $150, a 16% premium to the current price of $129.32. Bulls point to DTE's expanded five-year capital plan of $36.5 billion and management's projection of 6% to 8% EPS growth, with an emphasis on hitting the upper end of that range. The bear case centres on a modest downward drift in the funds-from-operations-to-debt ratio targeting around 15%, initial 2026 EPS guidance that disappointed relative to prior expectations, and Michigan's lag in attracting data centre load relative to other utility territories. On factor scores, the standout is dividend quality, ranked at the 91st percentile. Forward EPS growth ranks at the 82nd percentile, and EPS surprise at the 78th. Value metrics are weaker, with the EV/EBIT factor at just the 32nd percentile. The P/E multiple is near 15.8x trailing, up about 0.35 points over the past 30 days.

Options positioning skews toward calls. The put/call ratio came in at 0.18 on October 20, below its 20-day average of 0.22 and near the lower end of the past year's range (the 52-week low is 0.09). That is not a reading of elevated hedging demand. If anything, options flow this week reflects a muted defensive posture ahead of the October 29 print.

DTE's closest peers have outrun it on the week. CMS gained 3.2%, ED rose 3.9%, and NI added 3.1%, while DTE moved just 0.8%. CNP and WEC also posted stronger weekly returns. That divergence, combined with the steady short rebuild, makes the October 29 earnings release the immediate focal point for how the position resolves.

Stocks in this article

See the live data behind this article on ORTEX.

Open DTE on ORTEX →

How this article was generated

Generated
21 Oct 2026, 18:20
Data as of
21 Oct 2026, 18:16
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.